4 results  1 of 1 

1 Basiliximab-Induced Non-Cardiogenic Pulmonary Edema in a Kidney Transplant Patient
Yoo Jin Lee, Bong Soo Park, Sihyung Park, Kang Min Park, Jin Han Park, Il Hwan Park, Yang Wook Kim
J Korean Soc Transplant.2018;32(3):63-68.   Published online 2018 September 27     DOI: http://dx.doi.org/10.4285/jkstn.2018.32.3.63
      
2 Comparison of the Clinical Outcomes between Anti-thymocyte Globulin and Basiliximab Induction Therapy in Deceased Donor Kidney Transplantation: Single Center Experience
Uk Cheon Seong, Ik Moon Ju, Seok Choi In, Hee Yoon Se, Min Hwang Won, Ro Yun Sung
J Korean Soc Transplant.2015;29(2):61-67.   Published online 2015 June 10     DOI: http://dx.doi.org/10.4285/jkstn.2015.29.2.61
   
3 Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients
Chang-Kwon Oh, Su Jin Kim, Ji Hye Kim, Jong Hoon Lee
J Korean Med Sci.2012;27(4):337-342.   Published online 2012 March 21     DOI: http://dx.doi.org/10.3346/jkms.2012.27.4.337
      
4 The Efficacy and Safety of an Immunosuppressive Regimen Including the Use of Mycophenolate Mofetil and an Interleukin-2 Monoclonal Antibody in Heart Transplant Patients
Jung-Min Ahn, Jae-Jung Kim, Meong-Gun Song, Hyoung Young Kim, Chang Hoon Lee, Jae-Kwan Song, Seong-Wook Park, Seung-Jung Park, In Ok Kim
Korean Circ J.2006;36(12):794-801.   Published online 2006 December 31     DOI: http://dx.doi.org/10.4070/kcj.2006.36.12.794
      

 1 of 1